Revelar Biotherapeutics, Inc. — Form D
Revelar Biotherapeutics, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-18. The offering totals $22.5M, of which $17.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-18
- Form: D
- Accession: 0001894366-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $17.5M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2021-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421689
Issuer
- Name: Revelar Biotherapeutics, Inc.
- CIK: 0001894366
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 9630 EAGLE RIDGE DRIVE, BETHESDA, MD, 20817
- Phone: 203-530-4466
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paul Fonteyne | Director | New Haven, CT |
| David Scheer | Director | Foster City, CA |
| Brett Giroir | Director | College Park, GA |
| Laurence Smith | Executive Officer | New York, NY |
| Glenn Marina | Director | Bethesda, MD |
| Glenn Marina | Executive Officer | Bethesda, MD |
Other filings by this issuer (1)
More